INVITRO ACTIVITY OF A NEW BROAD-SPECTRUM, BETA-LACTAMASE-STABLE ORAL CEPHALOSPORIN, CEFIXIME

被引:40
作者
NEU, HC
机构
关键词
D O I
10.1097/00006454-198710000-00034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:958 / 962
页数:5
相关论文
共 7 条
[1]   INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C ;
AYERS, LW ;
GAVAN, TL ;
GERLACH, EH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162
[2]   INVITRO AND INVIVO ANTIBACTERIAL PROPERTIES OF FK-027, A NEW ORALLY ACTIVE CEPHEM ANTIBIOTIC [J].
KAMIMURA, T ;
KOJO, H ;
MATSUMOTO, Y ;
MINE, Y ;
GOTO, S ;
KUWAHARA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :98-104
[3]  
MANDELL GL, 1986, PRINCIPLES PRACTICE, P180
[4]   COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].
NEU, HC ;
CHIN, NX ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180
[5]  
NEU HC, 1986, ANTIBIOTICS LABORATO, P757
[6]  
NEU HC, 1986, REV NEW ORAL CEPHALO, P31
[7]  
OGRADY FW, 1986, REV NEW ORAL CEPHALO, P23